These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 11357949
1. Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia. Lodi R, Hart PE, Rajagopalan B, Taylor DJ, Crilley JG, Bradley JL, Blamire AM, Manners D, Styles P, Schapira AH, Cooper JM. Ann Neurol; 2001 May; 49(5):590-6. PubMed ID: 11357949 [Abstract] [Full Text] [Related]
2. Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up. Hart PE, Lodi R, Rajagopalan B, Bradley JL, Crilley JG, Turner C, Blamire AM, Manners D, Styles P, Schapira AH, Cooper JM. Arch Neurol; 2005 Apr; 62(4):621-6. PubMed ID: 15824263 [Abstract] [Full Text] [Related]
3. Assessment of in vitro and in vivo mitochondrial function in Friedreich's ataxia and Huntington's disease. Schapira A, Lodi R. Methods Mol Biol; 2004 Apr; 277():293-307. PubMed ID: 15201464 [Abstract] [Full Text] [Related]
5. Identification and sizing of GAA trinucleotide repeat expansion, investigation for D-loop variations and mitochondrial deletions in Iranian patients with Friedreich's ataxia. Houshmand M, Panahi MS, Nafisi S, Soltanzadeh A, Alkandari FM. Mitochondrion; 2006 Apr; 6(2):82-8. PubMed ID: 16581313 [Abstract] [Full Text] [Related]
6. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA. J Neurol Sci; 2005 Jun 15; 233(1-2):145-62. PubMed ID: 15896810 [Abstract] [Full Text] [Related]
7. Neurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up. Ribaï P, Pousset F, Tanguy ML, Rivaud-Pechoux S, Le Ber I, Gasparini F, Charles P, Béraud AS, Schmitt M, Koenig M, Mallet A, Brice A, Dürr A. Arch Neurol; 2007 Apr 15; 64(4):558-64. PubMed ID: 17420319 [Abstract] [Full Text] [Related]
8. Cardiomyopathy in Friedreich's ataxia-assessment by cardiac MRI. Meyer C, Schmid G, Görlitz S, Ernst M, Wilkens C, Wilhelms I, Kraus PH, Bauer P, Tomiuk J, Przuntek H, Mügge A, Schöls L. Mov Disord; 2007 Aug 15; 22(11):1615-22. PubMed ID: 17546670 [Abstract] [Full Text] [Related]
9. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Puccio H, Simon D, Cossée M, Criqui-Filipe P, Tiziano F, Melki J, Hindelang C, Matyas R, Rustin P, Koenig M. Nat Genet; 2001 Feb 15; 27(2):181-6. PubMed ID: 11175786 [Abstract] [Full Text] [Related]
10. Friedreich's ataxia: coenzyme Q10 and vitamin E therapy. Cooper JM, Schapira AH. Mitochondrion; 2007 Jun 15; 7 Suppl():S127-35. PubMed ID: 17485244 [Abstract] [Full Text] [Related]
15. Bioenergetics of the calf muscle in Friedreich ataxia patients measured by 31P-MRS before and after treatment with recombinant human erythropoietin. Nachbauer W, Boesch S, Schneider R, Eigentler A, Wanschitz J, Poewe W, Schocke M. PLoS One; 2013 Dec 15; 8(7):e69229. PubMed ID: 23922695 [Abstract] [Full Text] [Related]